Page last updated: 2024-11-04

scriptaid and Cardiac Hypertrophy

scriptaid has been researched along with Cardiac Hypertrophy in 1 studies

scriptide: provokes translocation of GLUT4 to increase glucose uptake; structure in first source

Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.

Research Excerpts

ExcerptRelevanceReference
"In cell culture models of cardiac hypertrophy, pharmacological suppression of histone deacetylases (HDACs) can either blunt or amplify cell growth."1.33Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. ( Berenji, K; Hill, JA; Kong, Y; Lu, G; Olson, EN; Rothermel, BA; Tannous, P, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kong, Y1
Tannous, P1
Lu, G1
Berenji, K1
Rothermel, BA1
Olson, EN1
Hill, JA1

Other Studies

1 other study available for scriptaid and Cardiac Hypertrophy

ArticleYear
Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy.
    Circulation, 2006, Jun-06, Volume: 113, Issue:22

    Topics: Acetylation; Animals; Apoptosis; Cardiomegaly; Cell Proliferation; Dose-Response Relationship, Drug;

2006